लोड हो रहा है...
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
OBJECTIVE: Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of sorafenib plus cyproheptadine compared with sorafenib alone in patients with advanced hepatocellular carcinoma. METHODS: A retrospective cohort study reviewed all consecuti...
में बचाया:
| में प्रकाशित: | Jpn J Clin Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4376992/ https://ncbi.nlm.nih.gov/pubmed/25646358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv007 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|